Tailoring of asthma therapy based on FeNO (fractional exhaled nitric oxide) or sputum eosinophils has been shown to be effective in decreasing asthma exacerbations in adults. However an Australian-led systematic review and meta-analysis of the evidence for the use of the eosinophilic markers found they made no difference to daily symptom scores. While some have ...
Already a member?
Enter your email to keep reading.